Mirae Asset Global Investments Co. Ltd. raised its holdings in PetMed Express, Inc. (NASDAQ:PETS – Get Rating) by 46.3% during the 1st quarter, Holdings Channel.com reports. The firm owned 546,352 shares of the company’s stock after acquiring an additional 173,030 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in PetMed Express were worth $14,096,000 as of its most recent filing with the SEC.
Other hedge funds also recently added to or reduced their stakes in the company. Captrust Financial Advisors boosted its holdings in PetMed Express by 72.5% in the first quarter. Captrust Financial Advisors now owns 1,570 shares of the company’s stock valued at $41,000 after purchasing an additional 660 shares during the last quarter. US Bancorp DE boosted its holdings in PetMed Express by 319.1% in the first quarter. US Bancorp DE now owns 3,751 shares of the company’s stock valued at $97,000 after purchasing an additional 2,856 shares during the last quarter. Russell Investments Group Ltd. boosted its stake in shares of PetMed Express by 40.0% during the 1st quarter. Russell Investments Group Ltd. now owns 6,738 shares of the company’s stock worth $173,000 after acquiring an additional 1,924 shares in the last quarter. State of Tennessee Treasury Department boosted its stake in shares of PetMed Express by 17.9% during the 1st quarter. State of Tennessee Treasury Department now owns 7,696 shares of the company’s stock worth $199,000 after acquiring an additional 1,166 shares in the last quarter. Finally, SMH Capital Advisors Inc. purchased a new stake in shares of PetMed Express during the 1st quarter worth about $213,000. 85.52% of the stock is owned by hedge funds and other institutional investors.
PetMed Express Stock Down 1.1 %
PETS stock opened at $21.11 on Monday. The company’s 50-day simple moving average is $21.53 and its 200-day simple moving average is $22.75. PetMed Express, Inc. has a 52-week low of $19.08 and a 52-week high of $32.67. The firm has a market cap of $443.08 million, a P/E ratio of 21.99 and a beta of 0.58.
PetMed Express Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, August 19th. Investors of record on Friday, August 12th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Thursday, August 11th. This represents a $1.20 annualized dividend and a dividend yield of 5.68%. PetMed Express’s dividend payout ratio (DPR) is presently 125.00%.
Analyst Upgrades and Downgrades
Separately, Morgan Stanley lowered their target price on shares of PetMed Express from $20.00 to $19.00 and set an “underweight” rating on the stock in a research note on Tuesday, July 26th.
PetMed Express Profile
PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
- Get a free copy of the StockNews.com research report on PetMed Express (PETS)
- Kroger’s is Your One-Stop Consumer Staples Stock
- Adobe Perfects the Art of the Faceplant for Investors
- Tax Credits are the Incentives in the Inflation Reduction Act
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- 3 Banks Worth Considering For Q4
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.